Legal Representation
Attorney
Marc C. Levy
USPTO Deadlines
Application History
32 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 16, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Oct 16, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Feb 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 9, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Feb 9, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jan 24, 2023 | EXT5 | S | SOU EXTENSION 5 FILED |
| Jan 24, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 25, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 23, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Aug 23, 2022 | EXT4 | S | SOU EXTENSION 4 FILED |
| Aug 23, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 8, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 4, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Feb 4, 2022 | EXT3 | S | SOU EXTENSION 3 FILED |
| Feb 4, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 15, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 13, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Sep 13, 2021 | EXT2 | S | SOU EXTENSION 2 FILED |
| Sep 13, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 7, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Mar 16, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 12, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Mar 12, 2021 | EXT1 | S | SOU EXTENSION 1 FILED |
| Mar 12, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 15, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 21, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 21, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 1, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 13, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 13, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 26, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 26, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical and biologic preparations for the treatment of intestinal failure associated liver disease and other fatty liver diseases; pharmaceutical and biologic preparations for the treatment of maxillofacial cysts and other cavernous malformations; pharmaceutical and biologic preparations for the treatment of proliferative diseases
Classification
International Classes
005